- Home
- NWTN vs MGTX Comparison
NWTN vs MGTX Comparison
Compare NWTN & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTN
- MGTX
- Stock Information
- Founded
- NWTN 2016
- MGTX 2015
- Country
- NWTN United Arab Emirates
- MGTX United States
- Employees
- NWTN N/A
- MGTX N/A
- Industry
- NWTN Auto Manufacturing
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NWTN Consumer Discretionary
- MGTX Health Care
- Exchange
- NWTN Nasdaq
- MGTX Nasdaq
- Market Cap
- NWTN 546.4M
- MGTX 520.8M
- IPO Year
- NWTN N/A
- MGTX N/A
- Fundamental
- Price
- NWTN $1.79
- MGTX $8.47
- Analyst Decision
- NWTN
- MGTX Strong Buy
- Analyst Count
- NWTN 0
- MGTX 2
- Target Price
- NWTN N/A
- MGTX $24.00
- AVG Volume (30 Days)
- NWTN 146.2K
- MGTX 541.8K
- Earning Date
- NWTN 01-01-0001
- MGTX 08-11-2025
- Dividend Yield
- NWTN N/A
- MGTX N/A
- EPS Growth
- NWTN N/A
- MGTX N/A
- EPS
- NWTN N/A
- MGTX N/A
- Revenue
- NWTN $11,995,000.00
- MGTX $34,508,000.00
- Revenue This Year
- NWTN N/A
- MGTX $365.04
- Revenue Next Year
- NWTN N/A
- MGTX $73.18
- P/E Ratio
- NWTN N/A
- MGTX N/A
- Revenue Growth
- NWTN N/A
- MGTX 203.23
- 52 Week Low
- NWTN $0.30
- MGTX $3.85
- 52 Week High
- NWTN $3.48
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- NWTN 53.88
- MGTX 76.43
- Support Level
- NWTN $1.46
- MGTX $6.31
- Resistance Level
- NWTN $1.67
- MGTX $8.75
- Average True Range (ATR)
- NWTN 0.18
- MGTX 0.45
- MACD
- NWTN -0.02
- MGTX 0.19
- Stochastic Oscillator
- NWTN 54.07
- MGTX 89.55
About NWTN NWTN Inc.
NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world. Geographically, it operates in The United States, The United Arab Emirates, Mainland China.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.